Trial Profile
Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs Erdosteine (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 23 Mar 2015 New trial record